"The CARC concluded that the epidemiological studies in humans showed no association between glyphosate exposure and cancer of the following: oral cavity, esophagus, stomach, colon, rectum, colorectum, lung, pancreas, kidney, bladder, prostate, brain (gliomas), soft-tissue sarcoma, leukemia, or multiple myelomas," Neeley writes. "The International Agency for Research on Cancer, or IARC, in Lyon, France, assessed the carcinogenic potential of glyphosate in March 2015. The IARC concluded glyphosate was 'probably carcinogenic to humans'."
Monsanto, which markets glyphosate under the brand name Roundup, has been critical of the IARC assessment, was quick to take advantage of the EPA error, Neeley writes. Hugh Grant, Monsanto's chairman and CEO, said in a statement: "No pesticide regulator in the world considers glyphosate to be a carcinogen, and this conclusion by the U.S. EPA once again reinforces this important fact. Glyphosate has a 40-year history of safe and effective use. Unfortunately, last year's inconsistent classification by IARC generated unwarranted concern and confusion about this important agricultural tool. This rigorous assessment of the data by EPA builds on the sound conclusions of both the European and Canadian regulatory authorities and once again makes it clear that glyphosate does not cause cancer." (Read more)